Current and historical daily PE Ratio for G.Barekat Pharm (
XTEH:BRKT1
) from 2017 to May 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. G.Barekat Pharm stock (XTEH:BRKT1) PE ratio as of May 16 2024 is 0.
More Details
G.Barekat Pharm (XTEH:BRKT1) PE Ratio (TTM) Chart
G.Barekat Pharm (XTEH:BRKT1) PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 0
- 1
| G.Barekat Pharm PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
G.Barekat Pharm (XTEH:BRKT1) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
G.Barekat Pharm
ISIN : IRO1BRKT0003
Share Class Description:
XTEH:BRKT1: Ordinary SharesCompare
Compare
Traded in other countries / regions
BRKT1.Iran IPO Date
2017-02-08Description
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers